Levels and determinants of inflammatory biomarkers in a swiss population-based sample (CoLaus study)

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Marques Vidal, Pedro ^a   Bochud, Murielle ^a   Bastardot, François ^b   Lüscher, Thomas ^c   Ferrero, François ^d   Gaspoz, Jean Michel ^d   Paccaud, Fred ^a   Urwyler, Adrian ^e   von Känel, Roland ^f   Hock, Christoph ^g   Waeber, Gérard ^b   Preisig, Martin ^b   Vollenweider, Peter ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e University of Bern ^*  (Switzerland)

^f UNIVERSITY OF BERN   (Switzerland)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE;

ADULT; AGED; AGING; ARTICLE; BODY MASS; FEMALE; GENDER; HUMAN; INFLAMMATION; LEISURE; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; SMOKING; SWITZERLAND; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; REPRODUCIBILITY; RISK FACTOR;

ADULT; AGED; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SWITZERLAND;

EID: 79958251930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021002     Document Type: Article

References (35)

1. Ridker PM, Hennekens CH, Buring JE, Rifai N, (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843.
2. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, et al. (2002) Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 288: 980-987.
3. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, et al. (2008) Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 5: e78 10.1371/journal.pmed.0050078.
4. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM, (2002) Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 22: 1668-1673.
5. Colbert LH, Visser M, Simonsick EM, Tracy RP, Newman AB, et al. (2004) Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc 52: 1098-1104 10.1111/j.1532-5415.2004.52307.x.
6. Fischer CP, Berntsen A, Perstrup LB, Eskildsen P, Pedersen BK, (2007) Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports 17: 580-587 10.1111/j.1600-0838.2006.00602.x.
7. Welsh P, Woodward M, Rumley A, Lowe G, (2008) Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol 141: 852-861 10.1111/j.1365-2141.2008.07133.x.
8. Stowe RP, Peek MK, Cutchin MP, Goodwin JS, (2010) Plasma cytokine levels in a population-based study: relation to age and ethnicity. J Gerontol A Biol Sci Med Sci 65: 429-433 10.1093/gerona/glp198.
9. Firmann M, Mayor V, Marques-Vidal P, Bochud M, Pécoud A, et al. (2008) The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 8: 6.
10. Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V, (2000) Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 12: 1712-1716 10.1006/cyto.2000.0764.
11. Skeppholm M, Wallén NH, Blombäck M, Kallner A, (2008) Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations? Clin Chem Lab Med 46: 1175-1179 10.1515/CCLM.2008.219.
12. Vignali DA, (2000) Multiplexed particle-based flow cytometric assays. J Immunol Methods 243: 243-255.
13. dupont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL, (2005) Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 66: 175-191 10.1016/j.jri.2005.03.005.
14. Elshal MF, McCoy JP, (2006) Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 38: 317-323 10.1016/j.ymeth.2005.11.010.
15. Hornung R, Reed L, (1990) Estimation of average concentration in the presence of nondectable values. Appl Occup Environ Hyg 5: 46-51.
16. Schafer JL, (1997) Analysis of incomplete multivariate data New York Chapman & Hall.
17. Scuteri A, Orru M, Morrell C, Piras MG, Taub D, et al. (2011) Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA Study. Atherosclerosis 215: 459-464 10.1016/j.atherosclerosis.2010.12.023.
18. Fichorova RN, Richardson-Harman N, Alfano M, Belec L, Carbonneil C, et al. (2008) Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal Chem 80: 4741-4751 10.1021/ac702628q.
19. Chowdhury F, Williams A, Johnson P, (2009) Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J Immunol Methods 340: 55-64 10.1016/j.jim.2008.10.002.
20. Friebe A, Volk HD, (2008) Stability of tumor necrosis factor alpha, interleukin 6, and interleukin 8 in blood samples of patients with systemic immune activation. Arch Pathol Lab Med 132: 1802-1806.
21. Wong HL, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, et al. (2008) Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev 17: 3450-3456 10.1158/1055-9965.EPI-08-0311.
22. Roubenoff R, Harris TB, Abad LW, Wilson PW, Dallal GE, et al. (1998) Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci 53: M20-M26.
23. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, et al. (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52: 812-817.
24. DeRijk R, Michelson D, Karp B, Petrides J, Galliven E, et al. (1997) Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J Clin Endocrinol Metab 82: 2182-2191.
25. Bouman A, Schipper M, Heineman MJ, Faas MM, (2004) Gender difference in the non-specific and specific immune response in humans. Am J Reprod Immunol 52: 19-26 10.1111/j.1600-0897.2004.00177.x.
26. Balbay Y, Tikiz H, Baptiste RJ, Ayaz S, Sasmaz H, et al. (2001) Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction. Angiology 52: 109-114.
27. Stewart LK, Flynn MG, Campbell WW, Craig BA, Robinson JP, et al. (2007) The influence of exercise training on inflammatory cytokines and C-reactive protein. Med Sci Sports Exerc 39: 1714-1719 10.1249/mss.0b013e31811ece1c.
28. Cartier A, Côté M, Lemieux I, Pérusse L, Tremblay A, et al. (2009) Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr 89: 1307-1314 10.3945/ajcn.2008.27030.
29. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, et al. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82: 4196-4200.
30. Cartier A, Côté M, Lemieux I, Pérusse L, Tremblay A, et al. (2009) Age-related differences in inflammatory markers in men: contribution of visceral adiposity. Metabolism 58: 1452-1458 10.1016/j.metabol.2009.04.025.
31. Hager K, Machein U, Krieger S, Platt D, Seefried G, et al. (1994) Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging 15: 771-772.
32. Petersen AM, Pedersen BK, (2005) The anti-inflammatory effect of exercise. J Appl Physiol 98: 1154-1162 10.1152/japplphysiol.00164.2004.
33. Moon YS, Kim DH, Song DK, (2004) Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. Metabolism 53: 863-867.
34. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW, (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19: 972-978.
35. Tolonen H, Koponen P, Aromaa A, Conti S, Graff-Iversen S, et al. (2008) Review of health examination surveys in Europe. B18/2008: 1-379.